Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | December 18, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 6TIT | B7UCZ5 | VSV G_440 | |
| 7WPR | P04275 | VWF D'D3 dimer complexed with D1D2 at 4.39 angstron resolution(VWF tube) | |
| 7ZWH | P04275 | VWF Tubules of D1D2 and D'D3A1 domains | |
| 7PMV | P04275 | VWF Tubules of D1D2D'D3 domains | |
| 7PNF | P04275 | VWF Tubules of D1D2D'D3 domains | |
| 8D3D | P04275 | VWF tubule derived from dimeric D1-A1 | |
| 8D3C | P04275 | VWF tubule derived from monomeric D1-A1 | |
| 7R3C | P21836 | VX-inhibited acetylcholinesterase in complex with 2-((hydroxyimino)methyl)-1-(5-(4-methyl-3-nitrobenzamido)pentyl)pyridinium | |
| 8DTO | 8DTO | Vaccine elicited Antibody MU89 bound to CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 Env trimer | |
| 8DY6 | 8DY6 | Vaccine elicited Antibody MU89+S27Y bound to CH848.D949.10.17_N133D_N138T.DS.SOSIP.664 HIV-1 Env trimer | |
| 9BU6 | 9BU6 | Vaccine elicited Fab C968.180 with influenza H10 JD13 HA trimer | |
| 9BU6 | A0A059T4A1 | Vaccine elicited Fab C968.180 with influenza H10 JD13 HA trimer | |
| 9BU6 | A0A0B4UV34 | Vaccine elicited Fab C968.180 with influenza H10 JD13 HA trimer | |
| 9BU8 | A0A059T4A1 | Vaccine elicited Fab c115.131 with influenza H10 JD13 HA trimer | |
| 9BU8 | A0A0B4UV34 | Vaccine elicited Fab c115.131 with influenza H10 JD13 HA trimer | |
| 9BU8 | 9BU8 | Vaccine elicited Fab c115.131 with influenza H10 JD13 HA trimer | |
| 8G4M | Q2N0S7 | Vaccine-elicited human antibody 2C06 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
| 8G4M | Q2N0S6 | Vaccine-elicited human antibody 2C06 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
| 8G4M | 8G4M | Vaccine-elicited human antibody 2C06 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
| 8G4T | Q2N0S7 | Vaccine-elicited human antibody 2C09 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
| 8G4T | Q2N0S6 | Vaccine-elicited human antibody 2C09 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
| 8G4T | 8G4T | Vaccine-elicited human antibody 2C09 in complex with HIV-1 envelope trimer BG505 DS-SOSIP | |
| 3T7D | Q15JG1 | Vall from streptomyces hygroscopicus in complex with trehalose | |
| 8G82 | 8G82 | Vancomycin bound to D-Ala-D-Ser | |
| 7SLX | O95497 | Vanin-1 complexed with Compound 11 | |
| 7SLY | O95497 | Vanin-1 complexed with Compound 27 | |
| 7SLV | O95497 | Vanin-1 complexed with Compound 3 | |
| 7P56 | P26332 | Variant Surface Glycoprotein 2 (VSG2, MiTat1.2, VSG221) Bound to Calcium | |
| 7P5D | B3GVK1 | Variant Surface Glycoprotein 3 (VSG3, MiTat1.3, VSG224) mutant (serine 317 and 319 to alanine) | |
| 7P5A | B3GVK1 | Variant Surface Glycoprotein 3 (VSG3, MiTat1.3, VSG224) mutant (serine 317 to alanine), single O-linked glycosylated at Ser319 | |
| 7P5B | B3GVK1 | Variant Surface Glycoprotein 3 (VSG3, MiTat1.3, VSG224) mutant (serine 319 to alanine), single O-linked glycosylated at Ser317 | |
| 7P59 | B3GVK1 | Variant Surface Glycoprotein 3 (VSG3, MiTat1.3, VSG224) with two O-linked post-translational modifications | |
| 8OK5 | B3GVS7 | Variant Surface Glycoprotein VSG11 monomer with iodine | |
| 8OK6 | B3GVS7 | Variant Surface Glycoprotein VSG11 two monomers | |
| 8OK4 | B3GVS7 | Variant Surface Glycoprotein VSG11wt-Oil | |
| 8ONH | B3GVS7 | Variant Surface Glycoprotein VSG11wt-Oil | |
| 8B3E | M4SY06 | Variant Surface Glycoprotein VSG397 | |
| 8OK7 | M4T0B2 | Variant Surface Glycoprotein VSG558 NTD | |
| 8OK8 | M4SXH7 | Variant Surface Glycoprotein VSG615 | |
| 6Z7A | A0A291L8F4 | Variant Surface Glycoprotein VSGsur | |
| 6Z7B | A0A291L8F4 | Variant Surface Glycoprotein VSGsur bound to suramin | |
| 6Z7C | A0A291L8F4 | Variant Surface Glycoprotein VSGsur mutant H122A | |
| 6Z7D | A0A291L8F4 | Variant Surface Glycoprotein VSGsur mutant H122A soaked in 0.77 mM Suramin. | |
| 6Z7E | A0A291L8F4 | Variant Surface Glycoprotein VSGsur mutant H122A soaked in 7.7 mM suramin | |
| 6Z79 | A0A291L8F4 | Variant Surface Glycoprotein VSGsur, I3C ("Magic Triangle") derivative used for phasing of the structure and subsequently as a model for molecular replacement of native, mutants, and drug soaks. | |
| 7MIT | Q63664 | Vascular KATP channel: Kir6.1 SUR2B propeller-like conformation 1 | |
| 7MIT | Q63563 | Vascular KATP channel: Kir6.1 SUR2B propeller-like conformation 1 | |
| 7MJP | Q63664 | Vascular KATP channel: Kir6.1 SUR2B propeller-like conformation 2 | |
| 7MJP | Q63563 | Vascular KATP channel: Kir6.1 SUR2B propeller-like conformation 2 | |
| 7MJO | Q63664 | Vascular KATP channel: Kir6.1 SUR2B quatrefoil-like conformation 1 |
